Roche launches breast cancer drugs

| Updated on: Oct 12, 2015

Swiss drug major Roche has launched two new medicines in India to treat breast cancer, claiming increased survival benefit and improved quality of life for patients.

“The new drugs, ‘Perjeta’ and ‘Kadcyla’, have been shown to both extend survival and improve quality of life in their approved applications for metastatic HER2-positive breast cancer,” Roche Pharma India said in a statement.

The company, however, did not share the pricing details of the two drugs.

Published on January 22, 2018

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor

You May Also Like

Recommended for you